|
|||||
 |
|||||
 |
|||||
| Is a COVID-19 Booster the Answer for Myeloma Patients? | |||||
| Despite receiving vaccinations, immunocompromised individuals can develop very low levels of antibodies. France and Israel have approved a booster vaccination for the vulnerable. IMF Chairman Dr. Brian G.M. Durie says it’s time for the U.S. to do the same. | |||||
|
|||||
 |
|||||
| Register for the Best of 2021 ASCO & EHA Webinar to Learn About the Most Up-to-Date Myeloma Therapies | |||||
| What’s new in myeloma research? IMF Chairman Dr. Brian G.M. Durie discusses important new findings from the 2021 American Society of Clinical Oncology (ASCO) annual meeting that took place virtually from June 4-8 this year, and from the subsequent European Hematology Association’s (EHA) annual meeting. Dr. Durie explains the latest data in approachable terms that patients and caregivers can use in their everyday care decision-making. You won’t want to miss this essential webinar. At the end of the presentation, participants will have time to ask questions. | |||||
|
|||||
 |
|||||
| FDA Approves DARZALEX FASPRO® in Combination with Pomalidomide and Dexamethasone for Myeloma Patients After First or Subsequent Relapse | |||||
| According to a press release from Janssen Pharmaceutical Companies of Johnson & Johnson, the U.S. FDA has approved “DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in combination with pomalidomide and dexamethasone (Pd) for the treatment of adult patients with multiple myeloma who have received at least one prior line of therapy, including lenalidomide and a proteasome inhibitor." Read the full press release now. | |||||
|
|||||
 |
|||||
| Phase III OCEAN Study Updates Results About the Safety and Efficacy of Melphalan Flufenamide Combination Therapies | |||||
| Read this press release from Oncopeptides AB to learn about “updated results and safety measures based on the head-to-head phase III OCEAN study evaluating the efficacy and safety of melphalan flufenamide plus dexamethasone versus pomalidomide plus dexamethasone in patients with relapsed refractory multiple myeloma who have received 2 - 4 prior lines of therapy.” | |||||
|
|||||
 |
|||||
| Calling All Researchers: Submit Your Grant Applications | |||||
| The Brian D. Novis Research Grants honor IMF founder Brian Novis, who succumbed to multiple myeloma in July of 1992. The grants are awarded to researchers working in the field of multiple myeloma and related disorders, including smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), and immunoglobulin-derived amyloidosis. The 2022 grants will support senior research projects with $80,000 each and junior research projects with $50,000 each. The deadline to submit the applications is October 1, 2021. | |||||
|
|||||
 |
|||||
| Just Two Weeks Left to Win Your 10-Day Vacation in Hawaii | |||||
| Enter a raffle for only $50 to win a 10-day stay at the Villa Ono Oasis in historic Kailua-Kona, Hawaii, as pictured here. The winner will be able to book a vacation at the villa any time during the rest of 2021 or in 2022. The dates of the stay will be based on the winner’s availability and coordination with the property owner. The lucky raffle winner will be announced on August 1, 2021. | |||||
|
|||||
 |
|||||
| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series | |||||
| This Week’s Question: COVID-19 FAQ #34: How can myeloma patients protect themselves against the Delta variant? |
|||||
|
|||||
|
|||||
We Thank Our Sponsors: |
|||||
| Amgen, Bristol Myers Squibb, Karyopharm Therapeutics, Oncopeptides Inc., Sanofi-Genzyme, and Takeda Oncology |
|||||
| We also thank individuals like you for your continued support! | |||||
|
|||||
| Join the conversation at The International Myeloma Foundation | |||||
 Facebook: /Myeloma |  Twitter @IMFMyeloma |  Instagram @IMFmyelomawww.myeloma.org |
|||||
| This email was sent by: The International Myeloma Foundation 12650 Riverside Drive, Suite 206 North Hollywood, CA 91607-3421 Connect with the IMF InfoLine 1-800-452-2873 |
|||||
| We respect your privacy and your preferences for communications of this nature. Home • Unsubscribe • Privacy Policy |
|||||
| View as web page | |||||
Hope Society Membership Benefits
Your donations will help us cultivate the future by supporting the IMF core programs, including educational events, publications, the toll-free InfoLine, and more!
- New members can select a limited edition Hope Society gift as a thank you for joining!
When you donate, you are eligible to receive these gifts according to your donation level.
$10-$24 monthly gift: Choose a Pen or T-shirt
$25-$74 monthly gift: Choose any 2 gifts below!
$75 and up monthly gift: Choose any 3 gifts below!
Limited Edition Hope Society Gifts
 Pen |
 Mug |
 T-Shirt (please contact us to specify size: S, M, L, XL, or XXL) |
 Canteen |
 Plush Microfiber Blanket |
 |
Please contact Jonathan Weitz at jweitz@myeloma.org or (800) 452-2873 Ext. 254 to arrange for your gifts or to answer any questions you may have.
